Specifically, the senolytic effects of PA in older adults involved both the inhibition of the production of senescent cells (p21Cip1) and the removal of excess senescent cells (p16INK4a), whereas it only reduced excess senescent cells in sedentary adults with obesity. The gene discussed is CDKN2A; the disease is obesity due to melanocortin 4 receptor deficiency.